Browse the full directors' dealings record of Accretive Health, Inc., a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was disclosed on 12 February 2016 (Retenue fiscale). Among the most active insiders: FLANAGAN JOSEPH GERARD. Every trade is free.
10
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Accretive Health, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$57.10.
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 18,535 of 24,990 companies
35.4
score / 100
Value
43
Quality
28
FCF yld-4.9%
Earn yld4.6%
EV/EBITDA·
ROE-28%
Gross mgn13%
Net mgn6.6%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Accretive Health, Inc. is a company focused on revenue cycle management and healthcare services. It assists healthcare providers in enhancing their financial and operational performance.